The role of circadian clock genes in tumors

References

• Dobson CM. Dynamics and Timekeeping in Biological Systems. Annu Rev Biochem. 2014;83(1):159–164. doi:10.1146/annurev-biochem-013014-10272424606145
   PubMedGoogle Scholar
• Chaix A, Zarrinpar A, Panda S. The circadian coordination of cell biology. J Cell Biol. 2016;215(1):15–25. doi:10.1083/jcb.20160307627738003
   PubMed Web of Science ®Google Scholar
• Rosato E, Kyriacou CP. Origins of circadian rhythmicity. J Biol Rhythms. 2002;17(6):506–511. doi:10.1177/074873040223823212465883
   PubMed Web of Science ®Google Scholar
• Golombek DA, Rosenstein RE. Physiology of circadian entrainment. Physiol Rev. 2010;90(3):1063–1102. doi:10.1152/physrev.00009.200920664079
   PubMed Web of Science ®Google Scholar
• Greene MW. Circadian rhythms and tumor growth. Cancer Lett. 2012;318(2):115–123. doi:10.1016/j.canlet.2012.01.00122252116
   PubMed Web of Science ®Google Scholar
• Rohling JH, vanderLeest HT, Michel S, Vansteensel MJ, Meijer JH. Phase resetting of the mammalian circadian clock relies on a rapid shift of a small population of pacemaker neurons. PLoS One. 2011;6(9):e25437. doi:10.1371/journal.pone.002543721966529
   PubMed Web of Science ®Google Scholar
• Lowrey PL, Takahashi JS. Genetics of circadian rhythms in mammalian model organisms. Adv Genet. 2011;74:175–230. doi:10.1016/B978-0-12-387690-4.00006-421924978
   PubMed Web of Science ®Google Scholar
• Mohawk JA, Green CB, Takahashi JS. Central and peripheral circadian clocks in mammals. Annu Rev Neurosci. 2012;35:445–462. doi:10.1146/annurev-neuro-060909-15312822483041
   PubMed Web of Science ®Google Scholar
• Dibner C, Schibler U, Albrecht U. The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu Rev Physiol. 2010;72:517–549. doi:10.1146/annurev-physiol-021909-13582120148687
   PubMed Web of Science ®Google Scholar
• Storch KF, Lipan O, Leykin I, et al. Extensive and divergent circadian gene expression in liver and heart. Nature. 2002;417(6884):78–83. doi:10.1038/nature74411967526
   PubMed Web of Science ®Google Scholar
• Kramer A, Yang FC, Kraves S, Weitz CJ. A screen for secreted factors of the suprachiasmatic nucleus. Methods Enzymol. 2005;393:645–663. doi:10.1016/S0076-6879(05)93034-615817317
   PubMed Web of Science ®Google Scholar
• Schibler U, Sassone-Corsi P. A web of circadian pacemakers. Cell. 2002;111(7):919–922.12507418
   PubMed Web of Science ®Google Scholar
• Eckel-Mahan K, Sassone-Corsi P. Metabolism and the circadian clock converge. Physiol Rev. 2013;93(1):107–135. doi:10.1152/physrev.00016.201223303907
   PubMed Web of Science ®Google Scholar
• Reszka E, Zienolddiny S. Epigenetic Basis of Circadian Rhythm Disruption in Cancer. Methods Mol Biol. 2018;1856:173–201.30178252
   PubMedGoogle Scholar
• Crumbley C, Wang Y, Kojetin DJ, Burris TP. Characterization of the core mammalian clock component, NPAS2, as a REV-ERBalpha/RORalpha target gene. J Biol Chem. 2010;285(46):35386–35392. doi:10.1074/jbc.M110.12928820817722
   PubMed Web of Science ®Google Scholar
• Mazzoccoli G, Laukkanen MO, Vinciguerra M, Colangelo T, Colantuoni V. A timeless link between circadian patterns and disease. Trends Mol Med. 2016;22(1):68–81. doi:10.1016/j.molmed.2015.11.00726691298
   PubMed Web of Science ®Google Scholar
• Schibler U. Mammalian circadian cogwheels are parts of macromolecular machines. Mol Cell. 2017;67(5):727–729. doi:10.1016/j.molcel.2017.08.02428886333
   PubMed Web of Science ®Google Scholar
• Aryal RP, Kwak PB, Tamayo AG, et al. Macromolecular assemblies of the mammalian circadian clock. Mol Cell. 2017;67(5):770–782.e776. doi:10.1016/j.molcel.2017.07.01728886335
   PubMed Web of Science ®Google Scholar
• Nernpermpisooth N, Qiu S, Mintz JD, et al. Obesity alters the peripheral circadian clock in the aorta and microcirculation. Microcirculation. 2015;22(4):257–266. doi:10.1111/micc.1219225660131
   PubMed Web of Science ®Google Scholar
• Pinho M, Sehmbi M, Cudney LE, et al. The association between biological rhythms, depression, and functioning in bipolar disorder: a large multi-center study. Acta Psychiatr Scand. 2016;133(2):102–108. doi:10.1111/acps.1244226010130
   PubMed Web of Science ®Google Scholar
• Gery S, Koeffler HP. Circadian rhythms and cancer. Cell Cycle. 2010;9(6):1097–1103. doi:10.4161/cc.9.6.1104620237421
   PubMed Web of Science ®Google Scholar
• Cao Q, Gery S, Dashti A, et al. A role for the clock gene per1 in prostate cancer. Cancer Res. 2009;69(19):7619–7625. doi:10.1158/0008-5472.CAN-08-419919752089
   PubMed Web of Science ®Google Scholar
• Lahti TA, Partonen T, Kyyronen P, Kauppinen T, Pukkala E. Night-time work predisposes to non-Hodgkin lymphoma. Int J Cancer. 2008;123(9):2148–2151. doi:10.1002/ijc.2356618697199
   PubMed Web of Science ®Google Scholar
• Hansen J. Increased breast cancer risk among women who work predominantly at night. Epidemiology. 2001;12(1):74–77.11138824
   PubMed Web of Science ®Google Scholar
• Schernhammer ES, Laden F, Speizer FE, et al. Rotating night shifts and risk of breast cancer in women participating in the nurses‘ health study. J Natl Cancer Inst. 2001;93(20):1563–1568.11604480
   PubMedGoogle Scholar
• Davis S, Mirick DK, Stevens RG. Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst. 2001;93(20):1557–1562.11604479
   PubMedGoogle Scholar
• Stevens RG, Rea MS. Light in the built environment: potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Causes Control. 2001;12(3):279–287. doi:10.1023/A:101123700060911405333
   PubMed Web of Science ®Google Scholar
• Berson DM, Dunn FA, Takao M. Phototransduction by retinal ganglion cells that set the circadian clock. Science. 2002;295(5557):1070–1073. doi:10.1126/science.106726211834835
   PubMed Web of Science ®Google Scholar
• Flynn-Evans EE, Stevens RG, Tabandeh H, Schernhammer ES, Lockley SW. Total visual blindness is protective against breast cancer. Cancer Causes Control. 2009;20(9):1753–1756. doi:10.1007/s10552-009-9405-019649715
   PubMed Web of Science ®Google Scholar
• Stevens RG. Circadian disruption and breast cancer: from melatonin to clock genes. Epidemiology. 2005;16(2):254–258.15703542
   PubMed Web of Science ®Google Scholar
• Kos-Kudla B, Ostrowska Z, Kozlowski A, et al. Circadian rhythm of melatonin in patients with colorectal carcinoma. Neuro Endocrinol Lett. 2002;23(3):239–242.12080285
   PubMed Web of Science ®Google Scholar
• Keith LG, Oleszczuk JJ, Laguens M. Circadian rhythm chaos: a new breast cancer marker. Int J Fertil Womens Med. 2001;46(5):238–247.11720196
   PubMedGoogle Scholar
• Gasche JA, Goel A. Epigenetic mechanisms in oral carcinogenesis. Future Oncol. 2012;8(11):1407–1425. doi:10.2217/fon.12.13823148615
   PubMed Web of Science ®Google Scholar
• Masri S, Kinouchi K, Sassone-Corsi P. Circadian clocks, epigenetics, and cancer. Curr Opin Oncol. 2015;27(1):50–56. doi:10.1097/CCO.000000000000015325405464
   PubMed Web of Science ®Google Scholar
• Joska TM, Zaman R, Belden WJ. Regulated DNA methylation and the circadian clock: implications in cancer. Biology. 2014;3(3):560–577. doi:10.3390/biology303056025198253
   PubMedGoogle Scholar
• Straif K, Baan R, Grosse Y, et al. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. 2007;8(12):1065–1066. doi:10.1016/S1470-2045(07)70373-X19271347
   PubMed Web of Science ®Google Scholar
• Kettner NM, Voicu H, Finegold MJ, et al. Circadian homeostasis of liver metabolism suppresses hepatocarcinogenesis. Cancer Cell. 2016;30(6):909–924. doi:10.1016/j.ccell.2016.10.00727889186
   PubMed Web of Science ®Google Scholar
• Dauchy RT, Xiang S, Mao L, et al. Circadian and melatonin disruption by exposure to light at night drives intrinsic resistance to tamoxifen therapy in breast cancer. Cancer Res. 2014;74(15):4099–4110. doi:10.1158/0008-5472.CAN-13-315625062775
   PubMed Web of Science ®Google Scholar
• Papagiannakopoulos T, Bauer MR, Davidson SM, et al. Circadian rhythm disruption promotes lung tumorigenesis. Cell Metab. 2016;24(2):324–331. doi:10.1016/j.cmet.2016.07.00127476975
   PubMed Web of Science ®Google Scholar
• Duffy SA, Teknos T, Taylor JM, et al. Health behaviors predict higher interleukin-6 levels among patients newly diagnosed with head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2013;22(3):374–381. doi:10.1158/1055-9965.EPI-12-098723300019
   PubMed Web of Science ®Google Scholar
• Duffield GE. DNA microarray analyses of circadian timing: the genomic basis of biological time. J Neuroendocrinol. 2003;15(10):991–1002.12969245
   PubMed Web of Science ®Google Scholar
• Qu Y, Wang Z, Huang X, et al. Circadian telomerase activity and DNA synthesis for timing peptide administration. Peptides. 2003;24(3):363–369.12732333
   PubMed Web of Science ®Google Scholar
• Koike N, Yoo SH, Huang HC, et al. Transcriptional architecture and chromatin landscape of the core circadian clock in mammals. Science. 2012;338(6105):349–354. doi:10.1126/science.122633922936566
   PubMed Web of Science ®Google Scholar
• Mure LS, Le HD. Diurnal transcriptome atlas of a primate across major neural and peripheral tissues. Science. 2018;359:6381. doi:10.1016/j.bbr.2018.10.026
   Web of Science ®Google Scholar
• Miller BH, McDearmon EL, Panda S, et al. Circadian and CLOCK-controlled regulation of the mouse transcriptome and cell proliferation. Proc Natl Acad Sci U S A. 2007;104(9):3342–3347. doi:10.1073/pnas.061172410417360649
   PubMed Web of Science ®Google Scholar
• Hunt T, Sassone-Corsi P. Riding tandem: circadian clocks and the cell cycle. Cell. 2007;129(3):461–464.17482541
   PubMed Web of Science ®Google Scholar
• Eismann EA, Lush E, Sephton SE. Circadian effects in cancer-relevant psychoneuroendocrine and immune pathways. Psychoneuroendocrinology. 2010;35(7):963–976. doi:10.1016/j.psyneuen.2009.12.01120097011
   PubMed Web of Science ®Google Scholar
• Huang XL, Fu CJ, Bu RF. Role of circadian clocks in the development and therapeutics of cancer. J Int Med Res. 2011;39(6):2061–2066. doi:10.1177/14732300110390060122289520
   PubMed Web of Science ®Google Scholar
• Sotak M, Sumova A, Pacha J. Cross-talk between the circadian clock and the cell cycle in cancer. Ann Med. 2014;46(4):221–232. doi:10.3109/07853890.2014.89229624779962
   PubMed Web of Science ®Google Scholar
• Bjarnason GA, Jordan RC, Wood PA, et al. Circadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phases. Am J Pathol. 2001;158(5):1793–1801. doi:10.1016/S0002-9440(10)64135-111337377
   PubMed Web of Science ®Google Scholar
• Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science. 2003;302(5643):255–259. doi:10.1126/science.108627112934012
   PubMed Web of Science ®Google Scholar
• Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell. 2002;111(1):41–50.12372299
   PubMed Web of Science ®Google Scholar
• Tan XM, Ye H, Yang K, et al. Circadian variations of clock gene Per2 and cell cycle genes in different stages of carcinogenesis in golden hamster buccal mucosa. Sci Rep. 2015;5:9997. doi:10.1038/srep0999725950458
   PubMed Web of Science ®Google Scholar
• Borgs L, Beukelaers P, Vandenbosch R, Belachew S, Nguyen L, Cell MB. “circadian” cycle: new role for mammalian core clock genes. Cell Cycle. 2009;8(6):832–837. doi:10.4161/cc.8.6.786919221497
   PubMed Web of Science ®Google Scholar
• Dang CV. MYC on the path to cancer. Cell. 2012;149(1):22–35. doi:10.1016/j.cell.2012.03.00322464321
   PubMed Web of Science ®Google Scholar
• Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem. 2004;73:39–85. doi:10.1146/annurev.biochem.73.011303.07372315189136
   PubMed Web of Science ®Google Scholar
• Grechez-Cassiau A, Rayet B, Guillaumond F, Teboul M, Delaunay F. The circadian clock component BMAL1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation. J Biol Chem. 2008;283(8):4535–4542. doi:10.1074/jbc.M70557620018086663
   PubMed Web of Science ®Google Scholar
• Yang X, Wood PA, Ansell CM, et al. The circadian clock gene Per1 suppresses cancer cell proliferation and tumor growth at specific times of day. Chronobiol Int. 2009;26(7):1323–1339. doi:10.3109/0742052090343130119916834
   PubMed Web of Science ®Google Scholar
• Gery S, Komatsu N, Baldjyan L, Yu A, Koo D, Koeffler HP. The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell. 2006;22(3):375–382. doi:10.1016/j.molcel.2006.03.03816678109
   PubMed Web of Science ®Google Scholar
• Gu X, Xing L, Shi G, et al. The circadian mutation PER2(S662G) is linked to cell cycle progression and tumorigenesis. Cell Death Differ. 2012;19(3):397–405. doi:10.1038/cdd.2011.10321818120
   PubMed Web of Science ®Google Scholar
• Sato F, Wu Y, Bhawal UK, et al. PERIOD1 (PER1) has anti-apoptotic effects, and PER3 has pro-apoptotic effects during cisplatin (CDDP) treatment in human gingival cancer CA9-22 cells. Eur J Cancer. 2011;47(11):1747–1758. doi:10.1016/j.ejca.2011.02.02521459569
   PubMed Web of Science ®Google Scholar
• Sato F, Nagata C, Liu Y, et al. PERIOD1 is an anti-apoptotic factor in human pancreatic and hepatic cancer cells. J Biochem. 2009;146(6):833–838. doi:10.1093/jb/mvp12619675098
   PubMed Web of Science ®Google Scholar
• Elshazley M, Sato M, Hase T, et al. The circadian clock gene BMAL1 is a novel therapeutic target for malignant pleural mesothelioma. Int J Cancer. 2012;131(12):2820–2831. doi:10.1002/ijc.2759822510946
   PubMed Web of Science ®Google Scholar
• Canaple L, Kakizawa T, Laudet V. The days and nights of cancer cells. Cancer Res. 2003;63(22):7545–7552.14633665
   PubMed Web of Science ®Google Scholar
• Chan S, Rowbottom L, McDonald R, et al. Does the time of radiotherapy affect treatment outcomes? A review of the literature. Clin Oncol (R Coll Radiol). 2017;29(4):231–238. doi:10.1016/j.clon.2016.12.00528034487
   PubMed Web of Science ®Google Scholar
• Vincenzi B, Santini D, La Cesa A, Tonini G. Cancer chronotherapy: principles, applications, and perspectives. Cancer. 2003;98(4):881–882. author reply 882-883. doi:10.1002/cncr.1160012910534
   PubMed Web of Science ®Google Scholar
• Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature. 2009;461(7267):1071–1078. doi:10.1038/nature0846719847258
   PubMed Web of Science ®Google Scholar
• Harper JW, Elledge SJ. The DNA damage response: ten years after. Mol Cell. 2007;28(5):739–745. doi:10.1016/j.molcel.2007.11.01518082599
   PubMed Web of Science ®Google Scholar
• Purvis JE, Karhohs KW, Mock C, Batchelor E, Loewer A, Lahav G. p53 dynamics control cell fate. Science. 2012;336(6087):1440–1444. doi:10.1126/science.121835122700930
   PubMed Web of Science ®Google Scholar
• Fu XJ, Li HX, Yang K, Chen D, Tang H. The important tumor suppressor role of PER1 in regulating the cyclin-CDK-CKI network in SCC15 human oral squamous cell carcinoma cells. Onco Targets Ther. 2016;9:2237–2245. doi:10.2147/OTT.S10095227143919
   PubMed Web of Science ®Google Scholar
• Li HX, Fu XJ, Yang K, Chen D, Tang H, Zhao Q. The clock gene PER1 suppresses expression of tumor-related genes in human oral squamous cell carcinoma. Oncotarget. 2016;7(15):20574–20583. doi:10.18632/oncotarget.782726943040
   PubMedGoogle Scholar
• Yang X, He X, Yang Z, Jabbari E. Mammalian PER2 regulates AKT activation and DNA damage response. Biochem Cell Biol. 2012;90(6):675–682. doi:10.1139/o2012-02522905719
   PubMedGoogle Scholar
• Bouchard-Cannon P, Mendoza-Viveros L, Yuen A, Kaern M, Cheng HY. The circadian molecular clock regulates adult hippocampal neurogenesis by controlling the timing of cell-cycle entry and exit. Cell Rep. 2013;5(4):961–973. doi:10.1016/j.celrep.2013.10.03724268780
   PubMed Web of Science ®Google Scholar
• Gotoh T, Vila-Caballer M, Liu J, Schiffhauer S, Finkielstein CV. Association of the circadian factor Period 2 to p53 influences p53‘s function in DNA-damage signaling. Mol Biol Cell. 2015;26(2):359–372. doi:10.1091/mbc.E14-05-099425411341
   PubMed Web of Science ®Google Scholar
• Unsal-Kacmaz K, Chastain PD, Qu PP, et al. The human Tim/Tipin complex coordinates an Intra-S checkpoint response to UV that slows replication fork displacement. Mol Cell Biol. 2007;27(8):3131–3142. doi:10.1128/MCB.02190-0617296725
   PubMed Web of Science ®Google Scholar
• Yang X, Wood PA, Hrushesky WJ. Mammalian TIMELESS is required for ATM-dependent CHK2 activation and G2/M checkpoint control. J Biol Chem. 2010;285(5):3030–3034. doi:10.1074/jbc.M109.05023719996108
   PubMed Web of Science ®Google Scholar
• Engelen E, Janssens RC, Yagita K, Smits VA, van der Horst GT, Tamanini F. Mammalian TIMELESS is involved in period determination and DNA damage-dependent phase advancing of the circadian clock. PLoS One. 2013;8(2):e56623. doi:10.1371/journal.pone.005662323418588
   PubMed Web of Science ®Google Scholar
• Papp SJ, Huber AL, Jordan SD, et al. DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. Elife. 2015;4. doi:10.7554/eLife.04883.
   PubMed Web of Science ®Google Scholar
• Kim J, D‘Annibale S, Magliozzi R, et al. USP17- and SCFbetaTrCP–regulated degradation of DEC1 controls the DNA damage response. Mol Cell Biol. 2014;34(22):4177–4185. doi:10.1128/MCB.00530-1425202122
   PubMed Web of Science ®Google Scholar
• Wang F, Li C, Yongluo CL. The circadian gene clock plays an important role in cell apoptosis and the DNA damage response in vitro. Technol Cancer Res Treat. 2016;15(3):480–486. doi:10.1177/153303461558543325976934
   PubMed Web of Science ®Google Scholar
• Cotta-Ramusino C, McDonald ER 3rd, Hurov K, Sowa ME, Harper JW, Elledge SJ. A DNA damage response screen identifies RHINO, a 9-1-1 and TopBP1 interacting protein required for ATR signaling. Science. 2011;332(6035):1313–1317. doi:10.1126/science.120343021659603
   PubMed Web of Science ®Google Scholar
• Mullenders J, Fabius AW, Madiredjo M, Bernards R, Beijersbergen RL. A large scale shRNA barcode screen identifies the circadian clock component ARNTL as putative regulator of the p53 tumor suppressor pathway. PLoS One. 2009;4(3):e4798. doi:10.1371/journal.pone.000479819277210
   PubMed Web of Science ®Google Scholar
• Ryan KM, Phillips AC, Vousden KH. Regulation and function of the p53 tumor suppressor protein. Curr Opin Cell Biol. 2001;13(3):332–337.11343904
   PubMed Web of Science ®Google Scholar
• Miki T, Matsumoto T, Zhao Z, Lee CC. p53 regulates Period2 expression and the circadian clock. Nat Commun. 2013;4:2444. doi:10.1038/ncomms344424051492
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature. 2000;408(6810):307–310. doi:10.1038/3504267511099028
   PubMed Web of Science ®Google Scholar
• Xiong H, Yang Y, Yang K, Zhao D, Tang H, Ran X. Loss of the clock gene PER2 is associated with cancer development and altered expression of important tumor-related genes in oral cancer. Int J Oncol. 2018;52(1):279–287. doi:10.3892/ijo.2017.418029115399
   PubMed Web of Science ®Google Scholar
• Deng C, Zhang P, Harper JW, Elledge SJ, Leder P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell. 1995;82(4):675–684.7664346
   PubMed Web of Science ®Google Scholar
• el-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993;75(4):817–825.8242752
   PubMed Web of Science ®Google Scholar
• Hua H, Wang Y, Wan C, et al. Circadian gene mPer2 overexpression induces cancer cell apoptosis. Cancer Sci. 2006;97(7):589–596. doi:10.1111/j.1349-7006.2006.00225.x16827798
   PubMed Web of Science ®Google Scholar
• Sun CM, Huang SF, Zeng JM, et al. Per2 inhibits k562 leukemia cell growth in vitro and in vivo through cell cycle arrest and apoptosis induction. Pathol Oncol Res. 2010;16(3):403–411. doi:10.1007/s12253-009-9227-019957060
   PubMed Web of Science ®Google Scholar
• Gotoh T, Vila-Caballer M, Santos CS, Liu J, Yang J, Finkielstein CV. The circadian factor Period 2 modulates p53 stability and transcriptional activity in unstressed cells. Mol Biol Cell. 2014;25(19):3081–3093. doi:10.1091/mbc.E14-05-099325103245
   PubMed Web of Science ®Google Scholar
• Lee S, Donehower LA, Herron AJ, Moore DD, Fu L. Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice. PLoS One. 2010;5(6):e10995. doi:10.1371/journal.pone.001099520539819
   PubMed Web of Science ®Google Scholar
• Liu J, Zou X. Distinct control of PERIOD2 degradation and circadian rhythms by the oncoprotein and ubiquitin ligase MDM2. Sci Signal. 2018;11(556).
   Web of Science ®Google Scholar
• Wang Y, Solt LA, Kojetin DJ, Burris TP. Regulation of p53 stability and apoptosis by a ROR agonist. PLoS One. 2012;7(4):e34921. doi:10.1371/journal.pone.003492122509368
   PubMed Web of Science ®Google Scholar
• Altman BJ, Hsieh AL, Sengupta A, et al. MYC disrupts the circadian clock and metabolism in cancer cells. Cell Metab. 2015;22(6):1009–1019. doi:10.1016/j.cmet.2015.09.00326387865
   PubMed Web of Science ®Google Scholar
• Walz S, Lorenzin F, Morton J, et al. Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles. Nature. 2014;511(7510):483–487. doi:10.1038/nature1347325043018
   PubMed Web of Science ®Google Scholar
• Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013;45(10):1127–1133. doi:10.1038/ng.276224071851
   PubMed Web of Science ®Google Scholar
• Boone DN, Qi Y, Li Z, Hann SR. Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism. Proc Natl Acad Sci U S A. 2011;108(2):632–637. doi:10.1073/pnas.100884810821187408
   PubMed Web of Science ®Google Scholar
• Wang C, Tai Y, Lisanti MP, Liao DJ. c-Myc induction of programmed cell death may contribute to carcinogenesis: a perspective inspired by several concepts of chemical carcinogenesis. Cancer Biol Ther. 2011;11(7):615–626. doi:10.4161/cbt.11.7.1468821278493
   PubMed Web of Science ®Google Scholar
• Soucek L, Whitfield JR, Sodir NM, et al. Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice. Genes Dev. 2013;27(5):504–513. doi:10.1101/gad.205542.11223475959
   PubMed Web of Science ®Google Scholar
• Felsher DW. MYC inactivation elicits oncogene addiction through both tumor cell-intrinsic and host-dependent mechanisms. Genes Cancer. 2010;1(6):597–604. doi:10.1177/194760191037779821037952
   PubMedGoogle Scholar
• Lin CY, Loven J, Rahl PB, et al. Transcriptional amplification in tumor cells with elevated c-Myc. Cell. 2012;151(1):56–67. doi:10.1016/j.cell.2012.08.02623021215
   PubMed Web of Science ®Google Scholar
• Sabo A, Kress TR, Pelizzola M, et al. Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis. Nature. 2014;511(7510):488–492. doi:10.1038/nature1353725043028
   PubMed Web of Science ®Google Scholar
• Wolf E, Lin CY, Eilers M, Levens DL. Taming of the beast: shaping Myc-dependent amplification. Trends Cell Biol. 2015;25(4):241–248. doi:10.1016/j.tcb.2014.10.00625475704
   PubMed Web of Science ®Google Scholar
• Kress TR, Sabo A, Amati B. MYC: connecting selective transcriptional control to global RNA production. Nat Rev Cancer. 2015;15(10):593–607. doi:10.1038/nrc398426383138
   PubMed Web of Science ®Google Scholar
• Lorenzin F, Benary U, Baluapuri A, et al. Different promoter affinities account for specificity in MYC-dependent gene regulation. Elife. 2016;5.
   PubMed Web of Science ®Google Scholar
• Huber AL, Papp SJ, Chan AB, et al. CRY2 and FBXL3 Cooperatively Degrade c-MYC. Mol Cell. 2016;64(4):774–789. doi:10.1016/j.molcel.2016.10.01227840026
   PubMed Web of Science ®Google Scholar
• Repouskou A, Sourlingas TG, Sekeri-Pataryas KE, Prombona A. The circadian expression of c-MYC is modulated by the histone deacetylase inhibitor trichostatin A in synchronized murine neuroblastoma cells. Chronobiol Int. 2010;27(4):722–741. doi:10.3109/0742052100378680020560708
   PubMed Web of Science ®Google Scholar
• Shostak A, Ruppert B, Ha N, et al. MYC/MIZ1-dependent gene repression inversely coordinates the circadian clock with cell cycle and proliferation. Nat Commun. 2016;7:11807. doi:10.1038/ncomms1180727339797
   PubMed Web of Science ®Google Scholar
• Repouskou A, Prombona A. c-MYC targets the central oscillator gene Per1 and is regulated by the circadian clock at the post-transcriptional level. Biochim Biophys Acta. 2016;1859(4):541–552. doi:10.1016/j.bbagrm.2016.02.00126850841
   PubMed Web of Science ®Google Scholar
• Granda TG, Liu XH, Smaaland R, et al. Circadian regulation of cell cycle and apoptosis proteins in mouse bone marrow and tumor. FASEB J. 2005;19(2):304–306. doi:10.1096/fj.04-2665fje15545298
   PubMedGoogle Scholar
• Koyanagi S, Kuramoto Y, Nakagawa H, et al. A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells. Cancer Res. 2003;63(21):7277–7283.14612524
   PubMed Web of Science ®Google Scholar
• Falcao AS, Kataoka MS, Ribeiro NA, et al. A novel cell line derived from pleomorphic adenoma expresses MMP2, MMP9, TIMP1, TIMP2, and shows numeric chromosomal anomalies. PLoS One. 2014;9(8):e105231. doi:10.1371/journal.pone.010523125137137
   PubMed Web of Science ®Google Scholar
• Ye H, Yang K, Tan XM, Fu XJ, Li HX. Daily rhythm variations of the clock gene PER1 and cancer-related genes during various stages of carcinogenesis in a golden hamster model of buccal mucosa carcinoma. Onco Targets Ther. 2015;8:1419–1426. doi:10.2147/OTT.S8371026089690
   PubMed Web of Science ®Google Scholar
• Bjarnason GA, Jordan RC, Sothern RB. Circadian variation in the expression of cell-cycle proteins in human oral epithelium. Am J Pathol. 1999;154(2):613–622. doi:10.1016/S0002-9440(10)65306-010027418
   PubMed Web of Science ®Google Scholar
• Anea CB, Ali MI, Osmond JM, et al. Matrix metalloproteinase 2 and 9 dysfunction underlie vascular stiffness in circadian clock mutant mice. Arterioscler Thromb Vasc Biol. 2010;30(12):2535–2543. doi:10.1161/ATVBAHA.110.21437920829506
   PubMed Web of Science ®Google Scholar
• Zieker D, Jenne I, Koenigsrainer I, et al. Circadian expression of clock- and tumor suppressor genes in human oral mucosa. Cell Physiol Biochem. 2010;26(2):155–166. doi:10.1159/00032054720798499
   PubMedGoogle Scholar
• Jensen LD, Cao Z, Nakamura M, et al. Opposing effects of circadian clock genes bmal1 and period2 in regulation of VEGF-dependent angiogenesis in developing zebrafish. Cell Rep. 2012;2(2):231–241. doi:10.1016/j.celrep.2012.07.00522884368
   PubMed Web of Science ®Google Scholar
• Oda A, Katayose Y, Yabuuchi S, et al. Clock gene mouse period2 overexpression inhibits growth of human pancreatic cancer cells and has synergistic effect with cisplatin. Anticancer Res. 2009;29(4):1201–1209.19414365
   PubMed Web of Science ®Google Scholar
• Zhanfeng N, Yanhui L, Zhou F, Shaocai H, Guangxing L, Hechun X. Circadian genes Per1 and Per2 increase radiosensitivity of glioma in vivo. Oncotarget. 2015;6(12):9951–9958. doi:10.18632/oncotarget.317925760074
   PubMedGoogle Scholar
• Wu Y, Sato F, Uk B, et al. Basic helix-loop-helix transcription factors DEC1 and DEC2 regulate the paclitaxel-induced apoptotic pathway of MCF-7 human breast cancer cells. Int J Mol Med. 2011;27(4):491–495. doi:10.3892/ijmm.2011.61721327324
   PubMed Web of Science ®Google Scholar
• Liu Y, Sato F, Kawamoto T, et al. Anti-apoptotic effect of the basic helix-loop-helix (bHLH) transcription factor DEC2 in human breast cancer cells. Genes Cells. 2010;15(4):315–325. doi:10.1111/j.1365-2443.2010.01381.x20236182
   PubMed Web of Science ®Google Scholar
• Jung CH, Kim EM, Park JK, et al. Bmal1 suppresses cancer cell invasion by blocking the phosphoinositide 3-kinase-Akt-MMP-2 signaling pathway. Oncol Rep. 2013;29(6):2109–2113. doi:10.3892/or.2013.238123563360
   PubMed Web of Science ®Google Scholar
• Matsumoto CS, Almeida LO, Guimaraes DM, et al. PI3K-PTEN dysregulation leads to mTOR-driven upregulation of the core clock gene BMAL1 in normal and malignant epithelial cells. Oncotarget. 2016;7(27):42393–42407. doi:10.18632/oncotarget.987727285754
   PubMedGoogle Scholar
• Cully M, You H, Levine AJ, Mak TW. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer. 2006;6(3):184–192. doi:10.1038/nrc181916453012
   PubMed Web of Science ®Google Scholar
• Lee JH, Sancar A. Regulation of apoptosis by the circadian clock through NF-kappaB signaling. Proc Natl Acad Sci U S A. 2011;108(29):12036–12041. doi:10.1073/pnas.110812510821690409
   PubMed Web of Science ®Google Scholar
• Jensen LD, Cao Y. Clock controls angiogenesis. Cell Cycle. 2013;12(3):405–408. doi:10.4161/cc.2359623324349
   PubMed Web of Science ®Google Scholar
• Sato F, Uk B, Kawamoto T, et al. Basic-helix-loop-helix (bHLH) transcription factor DEC2 negatively regulates vascular endothelial growth factor expression. Genes Cells. 2008;13(2):131–144. doi:10.1111/j.1365-2443.2007.01153.x18233956
   PubMed Web of Science ®Google Scholar
• Hsu CM, Lin SF, Lu CT, Lin PM, Yang MY. Altered expression of circadian clock genes in head and neck squamous cell carcinoma. Tumour Biol. 2012;33(1):149–155. doi:10.1007/s13277-011-0258-222081375
   PubMed Web of Science ®Google Scholar
• Cao Q, Zhao X, Bai J, et al. Circadian clock cryptochrome proteins regulate autoimmunity. Proc Natl Acad Sci U S A. 2017;114(47):12548–12553. doi:10.1073/pnas.161911911429109286
   PubMed Web of Science ®Google Scholar
• Cermakian N, Lange T, Golombek D, et al. Crosstalk between the circadian clock circuitry and the immune system. Chronobiol Int. 2013;30(7):870–888. doi:10.3109/07420528.2013.78231523697902
   PubMed Web of Science ®Google Scholar
• Gibbs JE, Blaikley J, Beesley S, et al. The nuclear receptor REV-ERBalpha mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines. Proc Natl Acad Sci U S A. 2012;109(2):582–587. doi:10.1073/pnas.110675010922184247
   PubMed Web of Science ®Google Scholar
• Logan RW, Sarkar DK. Circadian nature of immune function. Mol Cell Endocrinol. 2012;349(1):82–90. doi:10.1016/j.mce.2011.06.03921784128
   PubMed Web of Science ®Google Scholar
• Riedel F, Zaiss I, Herzog D, Gotte K, Naim R, Hormann K. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma. Anticancer Res. 2005;25(4):2761–2765.16080523
   PubMed Web of Science ®Google Scholar
• Sephton S, Spiegel D. Circadian disruption in cancer: a neuroendocrine-immune pathway from stress to disease? Brain Behav Immun. 2003;17(5):321–328.12946654
   PubMed Web of Science ®Google Scholar
• Curtis AM, Bellet MM, Sassone-Corsi P, O‘Neill LA. Circadian clock proteins and immunity. Immunity. 2014;40(2):178–186. doi:10.1016/j.immuni.2014.02.00224560196
   PubMed Web of Science ®Google Scholar
• Taniguchi H, Fernandez AF, Setien F, et al. Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies. Cancer Res. 2009;69(21):8447–8454. doi:10.1158/0008-5472.CAN-09-055119861541
   PubMed Web of Science ®Google Scholar
• Sun Y, Yang Z, Niu Z, et al. MOP3, a component of the molecular clock, regulates the development of B cells. Immunology. 2006;119(4):451–460. doi:10.1111/j.1365-2567.2006.02456.x16925591
   PubMed Web of Science ®Google Scholar
• Spengler ML, Kuropatwinski KK, Comas M, et al. Core circadian protein CLOCK is a positive regulator of NF-kappaB-mediated transcription. Proc Natl Acad Sci U S A. 2012;109(37):E2457–E2465. doi:10.1073/pnas.120627410922895791
   PubMed Web of Science ®Google Scholar
• Arjona A, Sarkar DK. The circadian gene mPer2 regulates the daily rhythm of IFN-gamma. J Interferon Cytokine Res. 2006;26(9):645–649. doi:10.1089/jir.2006.26.64516978068
   PubMed Web of Science ®Google Scholar
• Yan J, Wang H, Liu Y, Shao C. Analysis of gene regulatory networks in the mammalian circadian rhythm. PLoS Comput Biol. 2008;4(10):e1000193. doi:10.1371/journal.pcbi.100019318846204
   PubMed Web of Science ®Google Scholar
• Narasimamurthy R, Hatori M, Nayak SK, Liu F, Panda S, Verma IM. Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines. Proc Natl Acad Sci U S A. 2012;109(31):12662–12667. doi:10.1073/pnas.120996510922778400
   PubMed Web of Science ®Google Scholar
• Zhou M, Wang W, Karapetyan S, et al. Redox rhythm reinforces the circadian clock to gate immune response. Nature. 2015;523(7561):472–476. doi:10.1038/nature1444926098366
   PubMed Web of Science ®Google Scholar
• Tong X, Buelow K, Guha A, Rausch R, Yin L. USP2a protein deubiquitinates and stabilizes the circadian protein CRY1 in response to inflammatory signals. J Biol Chem. 2012;287(30):25280–25291. doi:10.1074/jbc.M112.34078622669941
   PubMed Web of Science ®Google Scholar
• Sand L, Wallstrom M, Hirsch JM. Smokeless tobacco, viruses and oral cancer. Oral Health Dent Manag. 2014;13(2):372–378.24984650
   PubMedGoogle Scholar
• Yuan H, Li H, Ma H, et al. Genetic polymorphisms in key DNA repair genes and risk of head and neck cancer in a Chinese population. Exp Ther Med. 2012;3(4):719–724. doi:10.3892/etm.2012.47622969958
   PubMed Web of Science ®Google Scholar
• Amit M, Yen TC, Liao CT, et al. Improvement in survival of patients with oral cavity squamous cell carcinoma: an international collaborative study. Cancer. 2013;119(24):4242–4248. doi:10.1002/cncr.2835724114787
   PubMed Web of Science ®Google Scholar
• Wolff D, Hassfeld S, Hofele C. Influence of marginal and segmental mandibular resection on the survival rate in patients with squamous cell carcinoma of the inferior parts of the oral cavity. J Craniomaxillofac Surg. 2004;32(5):318–323. doi:10.1016/j.jcms.2004.05.00515458675
   PubMed Web of Science ®Google Scholar
• Johnson NW, Warnakulasuriya S, Gupta PC, et al. Global oral health inequalities in incidence and outcomes for oral cancer: causes and solutions. Adv Dent Res. 2011;23(2):237–246. doi:10.1177/002203451140208221490236
   PubMedGoogle Scholar
• Zhao N, Tang H, Yang K, Chen D. Circadian rhythm characteristics of oral squamous cell carcinoma growth in an orthotopic xenograft model. Onco Targets Ther. 2013;6:41–46. doi:10.2147/OTT.S3995523378773
   PubMed Web of Science ®Google Scholar
• Hsu CM, Lin PM, Lai CC, Lin HC, Lin SF, Yang MY. PER1 and CLOCK: potential circulating biomarkers for head and neck squamous cell carcinoma. Head Neck. 2014;36(7):1018–1026. doi:10.1002/hed.2340223784787
   PubMed Web of Science ®Google Scholar
• Chen R, Yang K, Zhao NB, et al. Abnormal expression of PER1 circadian-clock gene in oral squamous cell carcinoma. Onco Targets Ther. 2012;5:403–407. doi:10.2147/OTT.S3850823226027
   PubMed Web of Science ®Google Scholar
• Su X, Chen D, Yang K, et al. The circadian clock gene PER2 plays an important role in tumor suppression through regulating tumor-associated genes in human oral squamous cell carcinoma. Oncol Rep. 2017;38(1):472–480. doi:10.3892/or.2017.565328535015
   PubMed Web of Science ®Google Scholar
• Tang Q, Cheng B, Xie M, et al. Circadian clock gene Bmal1 inhibits tumorigenesis and increases paclitaxel sensitivity in tongue squamous cell carcinoma. Cancer Res. 2017;77(2):532–544. doi:10.1158/0008-5472.CAN-16-132227821487
   PubMed Web of Science ®Google Scholar